13F Pro quality score
Rank #1,146 of 2,925TOP 50%
Rankings refresh quarterly once 80% of peers have filed. Next update: ~Nov 14, 2026.
Reported revenue, net income and operating margin by fiscal year, from SBC Medical Group Holdings Inc's annual filings on SEC EDGAR.
| Period | Form | Revenue | Net income | Op. marginOperating margin |
|---|---|---|---|---|
| FY 2025 | 10-K | $173.6M | $51.0M | 38.9% |
| FY 2024 | 10-K | $205.4M | $46.6M | 34.2% |
| FY 2023 | 10-K | $193.5M | $39.4M | 36.5% |
Ranked by quality-factor profile and overlapping institutional ownership, from the latest 13F filings and SEC financials.
Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.
SBC Medical Group Holdings Inc (SBC) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores SBC at 56.6/100 on a composite quality score built from its SEC filings, placing it at rank #1,146 of 2,925 stocks — the top half of the AI-ranked universe. SBC scores in the top quartile across balance sheet strength (91.4), profitability (90.7), free cash flow (88.8). Areas of concern include revenue growth (8.4) and revenue scale (22.2), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q2 2026), SBC Medical Group Holdings Inc reports quarterly revenue of $49.2M, net income of $10.7M, an operating margin of 38.6%. Top institutional holders of SBC by reported 13-F value include Lumbard & Kellner, BlackRock, GEODE CAPITAL MANAGEMENT, based on the most recent SEC filings. SBC trades on the Nasdaq exchange and files with the SEC under CIK 1930313. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate SBC daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for SBC Medical Group Holdings Inc directly from SEC EDGAR.
Financials through the period ended SEC EDGAR: CIK 1930313 →